StonvexLoading…
StonvexStonvexStonvexCore line items from OPRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $614.83M | $480.65M | $396.83M | $331.04M |
Operating Income | $90.07M | $92.26M | $62.89M | $41.81M |
Net Income | $108.28M | $80.77M | $153.30M | $15.04M |
EPS (Diluted) | $1.19 | $0.90 | $1.69 | $0.14 |
Total Assets | $1.14B | $1.06B | $1.01B | $964.69M |
Total Liabilities | $132.53M | $115.48M | $91.09M | $76.47M |
Cash & Equivalents | $155.47M | $126.80M | $93.86M | $52.41M |
Free Cash Flow OCF − CapEx | $112.18M | $81.63M | $80.89M | $53.48M |
Shares Outstanding | Not available | 88.48M | 87.52M | 89.22M |